Showing results (151-160 of 165) with videos related to
Sort By:
Pageof 17
Obstetrics and Gynecology|May 2, 2007
Clinical and pathologic correlates in surgical stage II endometrial carcinomaDavid E Cohn, Emily M Woeste, Stacey Cacchio, et al.Journal for Immunotherapy of Cancer|March 15, 2022
Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancerStephanie Lheureux, Daniela E Matei, Panagiotis A Konstantinopoulos, et al.Gynecologic Oncology Reports|July 7, 2023
Assessment of the feasibility of same-day discharge following minimally invasive hysterectomy in the elderly populationPaulina J Haight, Rachael N Piver, David A Barrington, et al.Cancer|December 8, 2016
Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group studyAbigail D Winder, Kruti P Maniar, Jian-Jun Wei, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 5, 2025
Quality-adjusted time without symptoms of disease progression or toxicity of treatment in patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel versus carboplatin-paclitaxelDana M Chase, Jørn Herrstedt, Eirwen M Miller, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2009
Phase I active immunotherapy with combination of two chimeric, human epidermal growth factor receptor 2, B-cell epitopes fused to a promiscuous T-cell epitope in patients with metastatic and/or recurrent solid tumorsPravin T P Kaumaya, Kevin Chu Foy, Joan Garrett, et al.Gynecologic Oncology|December 14, 2021
Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An NRG oncology studyUrsula A Matulonis, Helen Q Huang, Virginia L Filiaci, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer IntergroupMichael A Bookman, Mark F Brady, William P McGuire, et al.Gynecologic Oncology|November 28, 2017
Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 StudyNeil S Horowitz, G Larry Maxwell, Austin Miller, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2012
Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group studyCharles F Levenback, Shamshad Ali, Robert L Coleman, et al.Pageof 17